Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
Li-Na Gao, Yun Zhang, Keenan Sterling, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 322

Showing 1-25 of 322 citing articles:

Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues
Sneha Kumari, Rishika Dhapola, Dibbanti HariKrishnaReddy
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 943-957
Closed Access | Times Cited: 122
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Felicia Liana Andronie-Cioară, Adriana Ioana Ardelean, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1869-1869
Open Access | Times Cited: 83
Integrated multimodal cell atlas of Alzheimer’s disease
Mariano I. Gabitto, Kyle J. Travaglini, Victoria M. Rachleff, et al.
Nature Neuroscience (2024)
Open Access | Times Cited: 50
Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis
Itsuki Terao, Wakako Kodama
Ageing Research Reviews (2024) Vol. 94, pp. 102203-102203
Closed Access | Times Cited: 42
Chitosan: An overview of biological activities, derivatives, properties, and current advancements in biomedical applications
Great Iruoghene Edo, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, Mohammed H. Al‐Mashhadani
Carbohydrate Research (2024) Vol. 542, pp. 109199-109199
Closed Access | Times Cited: 32
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Renqing Zhao
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
Samar R. Saleh, Aml Abd-Elmegied, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124218-124218
Closed Access | Times Cited: 17
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 16
Exploring Advancements in Early Detection of Alzheimer's Disease with Molecular Assays and Animal Models
Papihra Sethi, Rakesh Bhaskar, Krishna Kumar Singh, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102411-102411
Closed Access | Times Cited: 15
Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease
Jiangli Jin, Jiong Chen, Clémence Cavaillès, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 2
Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's‐related phenotypes
Yijia Feng, Shengya Wang, Danlu Yang, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 1
Tangeretin offers neuroprotection against colchicine-induced memory impairment in Wistar rats by modulating the antioxidant milieu, inflammatory mediators and oxidative stress in the brain tissue
Olalekan Bukunmi Ogunro, Mojisola Esther Karigidi, Gideon Ampoma Gyebi, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes
О. В. Долотов, Л. С. Иноземцева, N. F. Myasoedov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4999-4999
Open Access | Times Cited: 55
The Role of Brain-Derived Neurotrophic Factor (BDNF) in Diagnosis and Treatment of Epilepsy, Depression, Schizophrenia, Anorexia Nervosa and Alzheimer’s Disease as Highly Drug-Resistant Diseases: A Narrative Review
Aleksandra Gliwińska, Justyna Czubilińska-Łada, Gniewko Więckiewicz, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 163-163
Open Access | Times Cited: 32
The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model
Juyong Kim, Pilju Choi, Young‐Tae Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6827-6827
Open Access | Times Cited: 27
The effects of resistance exercise on cognitive function, amyloidogenesis, and neuroinflammation in Alzheimer’s disease
Caroline Vieira Azevedo, Debora Hashiguchi, Henrique Correia Campos, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 26
Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of Alzheimer’s disease
Jun Chang, Y.Y. Li, Xiaoqian Shan, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 3, pp. 619-628
Open Access | Times Cited: 25
Primary Hypothyroidism and Alzheimer’s Disease: A Tale of Two
Faisal Alanazi, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3405-3416
Open Access | Times Cited: 24
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 14
Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways
Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102211-102211
Closed Access | Times Cited: 13
Esketamine Prevents Postoperative Emotional and Cognitive Dysfunction by Suppressing Microglial M1 Polarization and Regulating the BDNF-TrkB Pathway in Ageing Rats with Preoperative Sleep Disturbance
Yuxin Wen, Jiawen Xu, Jiahong Shen, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5680-5698
Open Access | Times Cited: 11
Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer’s Disease and Other Neurodegenerative Diseases
Yang Sun, Sadequl Islam, Makoto Michikawa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1757-1757
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top